Join Emily and Alex (CEO and Founders of Duchenne UK) as they speak with Michela Guglieri, Neuromuscular Consultant at the John Walton Muscular Dystrophy Centre, to discuss important considerations around gene therapy clinical trials, including recruitment and how DUK is working to overcome many of the challenges associated with this potential treatment.